iodomesitylene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 77647 |
| SCHEMBL ID | 760815 |
| MeSH ID | M0534108 |
| Synonym |
|---|
| einecs 223-709-9 |
| nsc 68044 |
| 2,4,6-trimethyliodobenzene |
| iodo-2,4,6-trimethylbenzene |
| DIVK1C_001604 |
| nsc-68044 |
| 4028-63-1 |
| nsc68044 |
| CDS1_000564 |
| MAYBRIDGE1_002852 |
| SR-01000643683-1 |
| 2-iodomesitylene |
| HMS549J14 |
| inchi=1/c9h11i/c1-6-4-7(2)9(10)8(3)5-6/h4-5h,1-3h3 |
| gtpnxfkonrihrw-uhfffaoysa- |
| I0478 |
| mesityl iodide |
| 2-iodo-1,3,5-trimethylbenzene |
| 2-iodo-1,3,5-trimethyl-benzene |
| 1-iodo-2,4,6-trimethylbenzene |
| iodomesitylene |
| A825033 |
| 2-iodo-1,3,5-trimethyl-benzene;2-iodomesitylene |
| CCG-54594 |
| FT-0612679 |
| AM20040409 |
| benzene, 2-iodo-1,3,5-trimethyl- |
| AKOS015853821 |
| mfcd00013707 |
| SY029295 |
| SCHEMBL760815 |
| CD 07694 |
| 2-iodo-1,3,5-trimethylbenzene # |
| AC-22945 |
| CS-W007852 |
| DTXSID60193265 |
| jodmesitylen |
| AS-19323 |
| AC1617 |
| mesityliodide |
| 2-iodo-1 |
| EN300-189628 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||